- Sep 23, 2020
- Business Update
JD Health Diabetes Center Partners with Sanofi on Chronic Diabetes Management
by Hui Zhang
JD Health Diabetes Center announced that it will collaborate with Sanofi, a world-famous biopharmaceutical company, to facilitate better chronic diabetes management. Both sides will leverage their strengths to explore areas of online consultation, insulin cold chain distribution, and education of both medical institutions and patients.
With more than 100 years of global experience in the field of diabetes treatment, Sanofi is a leading innovator for insulin drugs and diabetes education. Through the cooperation, Sanofi will share its expertise in diabetes management with JD Health, so that the company is better equipped to provide professional medical advice to patients. Patients will be able to order diabetes treatment medicine through the JD app, and then pick up their medicine from the nearest pharmacy themselves, or can rely on JD’s effective cold-chain fulfillment capability, which ensures the insulin will be delivered in as fast as 30 minutes.
In addition, both sides will leverage their professional knowledge and experience to provide training to doctors, and knowledge sharing to patients in the form of livestreaming so as to improve the quality of online treatment and empower the management capability of JD Health Diabetes Center.
At present, the number of diabetic patients in China has exceeded 116 million, with disease management for the complicated disease being an ongoing struggle. JD Health launched the Diabetes Center on April 15th, leveraging JD’s strong technology capabilities in artificial intelligence, big data, and the Internet of things, combined with online consultation, prescription purchase and drug delivery capabilities of JD Internet Hospital. JD Health is developing a closed-loop, integrated online and offline, diabetes management mechanism, to comprehensively improve the efficiency of diabetes diagnoses and treatment.